The George Institute For Global Health
United Kingdom

News and Events

Media release: 

A drug increasingly being prescribed for treating sciatica has been revealed to be no better than placebo, in new research from The George Institute for Global Health.

With more women dying from chronic obstructive pulmonary disease (COPD) than breast and lung cancer combined, a new report co-authored by Professor Christine Jenkins from The George Institute for Global Health highlights the need for a new global approach to tackling the disease.

As a result of significant reductions in maternal and infant mortality over the past few decades, we have much to celebrate in terms of improving health outcomes for people around the world.

The American Heart Association’s renowned journal Circulation has interviewed The George Institute for Global Health’s Chief Scientist, Professor Anushka Patel, in a special edition focusing on women and heart disease.

The George Institute for Global Health and China's National Center for Chronic and Non-Communicable Disease Control and Prevention (NCNCD) have signed a Memorandum of Understanding to address the growing burden of injury and trauma in China.

‘It is important to me to be a role model, an example of a strong resilient Aboriginal woman who can achieve anything she sets her mind to.’

Media release: 

A small but clinically important trial of a new ultra-low dose four-in-one pill to treat high blood pressure has produced remarkable results.

Media release: 

Commonly used non-steroidal anti-inflammatory drugs used to treat back pain provide little benefit, but cause side effects, according to new research from The George Institute for Global Health.

Media release: 

The George Institute’s FoodSwitch program has been selected to participate in LAUNCH Food – a global challenge to improve health outcomes by enabling people to make healthy food choices.

Media release: 

The George Institute for Global Health and the University of New South Wales (UNSW) today announced their intention to form a strategic collaboration to bolster high-impact medical research and transform lives around the world, a priority of both organisations.